Key statistics
As of last trade Swedish Orphan Biovitrum AB (publ) (B6E:HAN) traded at 38.00, -2.56% below its 52-week high of 39.00, set on Feb 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 38.00 |
|---|---|
| High | 38.00 |
| Low | 38.00 |
| Bid | 38.34 |
| Offer | 38.70 |
| Previous close | 38.30 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 357.41m |
| Free float | 197.59m |
| P/E (TTM) | 312.92 |
| Market cap | 145.04bn SEK |
| EPS (TTM) | 1.30 SEK |
Data delayed at least 15 minutes, as of Feb 17 2026 07:01 GMT.
More ▼
- Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions
- Sobi Announces U.S. Food and Drug Administration Approves Doptelet® (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)
